Stocks Health care PYPD
NASDAQ · Health carePolyPid Ltd. (PYPD)
It posted a net loss of $34.2M. In fiscal 2025 capital spending exceeded operating cash flow by $28.1M. At December 31, 2025 it held $6.4M in cash against $988K of debt. Its latest periodic report to the SEC is the annual report (foreign issuer) (20-F) filed on February 25, 2026.
What PolyPid Ltd. does
PolyPid Ltd. is registered with the SEC under industry code SIC 3841 (Surgical & Medical Instruments & Apparatus). Its shares trade on NASDAQ under the ticker PYPD.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | n/a | -$34.2M | $2.09 | -$28.1M |
| 2024 | n/a | -$29M | $4.91 | -$22M |
| 2023 | n/a | -$23.9M | $16.93 | -$17.4M |
| 2022 | n/a | -$39.6M | $61.09 | -$36.1M |
| 2021 | n/a | -$42.6M | $68.27 | -$35M |
| 2020 | n/a | -$36.9M | $134.14 | -$22.4M |
Latest SEC filings
What PolyPid Ltd. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- August 13, 2026Passive stake changed SCHEDULE 13G/A
- August 12, 2026
- August 12, 2026
- August 12, 2026Passive stake changed SCHEDULE 13G/A
- August 12, 2026
- July 29, 2026
- July 21, 2026
- July 15, 2026
- June 10, 2026
- June 1, 2026
Questions about PYPD
What does PolyPid Ltd. do?
PolyPid Ltd. is registered with the SEC under industry code SIC 3841 (Surgical & Medical Instruments & Apparatus). Its shares trade on NASDAQ under the ticker PYPD.
Is PolyPid Ltd. profitable?
No. In fiscal 2025 it reported a net loss of $34.2M.
When did PolyPid Ltd. last report?
Its most recent periodic report is the annual report (foreign issuer) (20-F) filed on February 25, 2026. It covers the period to December 31, 2025. Its newest filing of any kind is the passive stake changed from August 13, 2026.
Similar companies
Follow PYPD
Get an email when PolyPid Ltd. files with the SEC: results, executive changes, material agreements and annual reports.
Follow PYPD: get an email when it filesWhere the numbers come from
Financial figures are the values PolyPid Ltd. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.